Medical Innovation Xccelerator™ (MIX)
Accelerating drug development using advanced tissue models
The development of new drugs is an expensive, lengthy, and risky process. Occasionally, resources are wasted on drug candidates that eventually turn out to have an undesirable kidney pharmacology and/or toxicology. We therefore offer contract research services using state-of-the-art tissue models, namely whole kidney perfusion and precision-cut kidney slices, to improve decision-making during the early stages of drug development.